Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.

The reactogenicities and immunogenicities of two influenza virus vaccines were compared in a placebo-controlled clinical trial among healthy ambulatory persons > or = 65 years old (mean age, 72 years). Volunteers were assigned randomly to receive 15-, 45-, or 135-micrograms doses of monovalent in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Keitel, W A, Cate, T R, Atmar, R L, Turner, C S, Nino, D, Dukes, C M, Six, H R, Couch, R B
Format: Artigo
Jezik:Inglês
Izdano: 1996
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC170397/
https://ncbi.nlm.nih.gov/pubmed/8877126
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki